Business · 21/11/1997
FDA Reopens Comment Period for Pregnancy Labeling of Human Prescription Drugs
The FDA is extending the comment period for its public hearing on pregnancy labeling requirements until January 12, 1998, following a request from the Pharmaceutical Research and Manufacturers of America for additional time to prepare comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →